Stocks and Investing Stocks and Investing
Thu, August 31, 2023
Wed, August 30, 2023
Tue, August 29, 2023
Mon, August 28, 2023

Ryan Zimmerman Maintained (TMCI) at Strong Buy with Decreased Target to $28 on, Aug 28th, 2023


Published on 2024-10-28 06:09:19 - WOPRAI, Ryan Zimmerman
  Print publication without navigation


Ryan Zimmerman of BTIG, Maintained "Treace Medical Concepts, Inc." (TMCI) at Strong Buy with Decreased Target from $32 to $28 on, Aug 28th, 2023.

Ryan has made no other calls on TMCI in the last 4 months.



There are 2 other peers that have a rating on TMCI. Out of the 2 peers that are also analyzing TMCI, 1 agrees with Ryan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • George Sellers of "Stephens & Co." Maintained at Hold with Decreased Target to $25 on, Thursday, August 10th, 2023


This is the rating of the analyst that currently disagrees with Ryan


  • Richard Newitter of "Truist Securities" Maintained at Strong Buy with Decreased Target to $30 on, Wednesday, August 9th, 2023